Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.
about
Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settingsThe effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based studyAssociation of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic reviewA Comprehensive Review of Hypertension in PregnancyDo acetylsalicylic acid and other antiplatelet drugs prevent preeclampsia?Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionAngiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study biasDiagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control studyMaternal obesity and energy intake as risk factors of pregnancy-induced hypertension among Iranian women.Pregnant women with gestational hypertension may have a high frequency of sleep disordered breathing.Comparing the effects of antenatal betamethasone on Doppler velocimetry between intrauterine growth restriction with and without preeclampsia.Preeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives.Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study.Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles.Risk factors on hypertensive disorders among Jordanian pregnant women.Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsia.The 12-lead ECG in peripartum cardiomyopathyCanadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.Vitamin D status in early pregnancy and risk of preeclampsia.Incidence of gestational hypertension in the Calgary Health Region from 1995 to 2004.Hemodynamic Response to Upper Airway Obstruction in Hypertensive and Normotensive Pregnant Women.Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study.The Role of Obstructive Sleep Apnea in Developing Gestational Hypertension and Preeclampsia.Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies.Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia.A Pregnant Woman with Lupus and Nephrotic-Range Proteinuria.
P2860
Q24792152-421DAC2F-F87C-4587-B4C1-261349B606A9Q24804078-62C79693-2DE7-4ADB-B15C-5484649A3F52Q26859762-4C8E0F88-1CFC-4F76-AFC4-C104AEF3112CQ27495953-AF587321-CF09-41CC-8C3B-90CE9623CEE1Q28192079-CFE45F97-A7A3-4612-B14F-8C5EF0288526Q30499043-99BC12A3-2663-4ADE-A5C0-383E30B88B1EQ30499045-455EA310-773D-4E82-B3D7-21CFB4C41688Q33267837-2BCDE720-5E84-48AB-B871-CBDA415FF9C2Q33327641-6E3DCA60-A26D-441D-B558-B888A791567AQ33610047-2563892F-1646-4E60-865F-690D77AB9EE5Q34025818-72F5F189-AF81-487C-B839-6584DB566935Q34026177-8E65DB83-D75C-4159-B948-D8B7ADA50BB5Q34072122-9BD2798D-7FA8-418C-82D0-B5B8A2BE7706Q34458539-709FE35A-E315-4F5D-96A3-FACBE05A24AEQ35110541-356099ED-DE37-4906-B9D2-C1F75D6BA2C1Q35567879-4616681E-AD96-4BEA-8AA6-BBB397D9C154Q36295102-B753B37F-6614-450D-B349-E51A1C2C0D06Q36621690-C3DEAD2D-9A59-45AF-8E73-3867DD963C84Q36754859-F708055B-A1AE-4014-8E5A-BB1DE9A35EF7Q36780030-1E65DC0B-5FFE-4712-9E99-ADDA53D6BCB4Q36869223-028F8FD7-15AF-4ACF-8436-27995030461EQ37073321-FBF77C8B-500E-44F4-81CE-7FBAD9F34985Q37098406-F5FD4E98-3755-4370-B240-0AF895A2A372Q37256236-40B640C5-0D3F-44C6-B422-5551B8CCC3F6Q37319876-DECB80EF-E29E-4198-96B5-AEF5469508ADQ37448587-2733D2E1-2810-42D9-B141-FDAA75D49D28Q37697103-69C2A210-47CC-436A-B755-2840D62CFB9BQ41248214-B0E45930-F170-4F9A-B508-8D55D1031529Q46890747-4B28E205-17AA-4314-846B-4713C318C61EQ47259219-4335604F-F942-49C9-99A6-96450D5D0088Q53379081-C7E36F22-33F8-4F17-AC27-935E0DB68A51
P2860
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@ast
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@en
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@nl
type
label
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@ast
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@en
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@nl
prefLabel
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@ast
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@en
Report of the Canadian Hyperte ...... ensive disorders in pregnancy.
@nl
P2093
P2860
P1476
Report of the Canadian Hyperte ...... tensive disorders in pregnancy
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z